Patents by Inventor R. Scott Obach

R. Scott Obach has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Aryl fused azapolycyclic compounds
    Patent number: 6858624
    Abstract: This invention is directed to compounds of the formula (I): and their pharmaceutically acceptable salts, wherein R1, R2, and R3 are as defined herein; intermediates for the synthesis of such compounds, pharmaceutical compositions containing such compounds; and methods of using such compounds in the treatment of nicotine addiction/withdrawal and CNS disorders.
    Type: Grant
    Filed: November 27, 2002
    Date of Patent: February 22, 2005
    Assignees: Pfizer, Inc., Pfizer Products, Inc.
    Inventors: Anne E. Hagen, R. Scott Obach
  • Use of CYP2D6 inhibitors in combination therapies
    Publication number: 20040028755
    Abstract: This invention relates to the use of a CYP2D6 inhibitor in combination with a drug having CYP2D6 catalyzed metabolism, wherein the drug and the CYP2D6 inhibitor are not the same compound; and pharmaceutical compositions for said use.
    Type: Application
    Filed: July 21, 2003
    Publication date: February 12, 2004
    Applicant: Pfizer Inc
    Inventor: R. Scott Obach
  • Use of CYP2D6 inhibitors in combination therapies
    Publication number: 20040018253
    Abstract: This invention relates to the use of a CYP2D6 inhibitor in combination with a drug having CYP2D6 catalyzed metabolism, wherein the drug and the CYP2D6 inhibitor are not the same compound; and pharmaceutical compositions for said use.
    Type: Application
    Filed: July 18, 2003
    Publication date: January 29, 2004
    Applicant: Pfizer Inc
    Inventor: R. Scott Obach
  • Aryl fused azapolycyclic compounds
    Publication number: 20030166582
    Abstract: This invention is directed to compounds of the formula (I): 1
    Type: Application
    Filed: November 27, 2002
    Publication date: September 4, 2003
    Applicant: Pfizer Inc.
    Inventors: Anne E. Hagen, R. Scott Obach
  • Use of CYP2D6 inhibitors in combination therapies
    Publication number: 20030144220
    Abstract: This invention relates to the use of a CYP2D6 inhibitor in combination with a drug having CYP2D6 catalyzed metabolism, wherein the drug and the CYP2D6 inhibitor are not the same compound; and pharmaceutical compositions for said use.
    Type: Application
    Filed: March 21, 2000
    Publication date: July 31, 2003
    Inventor: R. Scott Obach
  • 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
    Patent number: 6239147
    Abstract: This invention relates to novel 1-trifluoromethyl-4-hydroxy-7-piperidinylaminomethylchroman derivatives of the formula wherein R1 is C1-C6 alkyl; R2 is hydrogen, C1-C6 alkyl, halo C1-C6 alkyl or phenyl; R3 is hydrogen or halo; and R4 and R5 are independently hydrogen, C1-C6 alkyl or halo C1-C6 alkyl, their pharmaceutically acceptable salts, pharmaceutical compositions containing such compounds, and the use of such compounds to treat CNS, gastrointestinal and other disorders.
    Type: Grant
    Filed: May 17, 2000
    Date of Patent: May 29, 2001
    Assignee: Pfizer INC
    Inventors: R. Scott Obach, Douglas Alan Scully